A new study funded by the National Institute for Translational Medicine, and published in last month’s issue of the journal Molecular Neurobuology, has found that cannabis may treat, as well as reverse the symptoms of neurodegenerative diseases such as Parknson’s and Alzheimer’s. According to researchers; “Our findings support the potential of cannabidiol in reversing cognitive decline and its clinical use in treating neurodegenerative disorders such as Parkinson’s Disease and Alzheimer’s Disease.” For the study, researchers dosed rats with cannabidiol – a compound found in cannabis – and concluded that: CBD rescued iron-induced effects, bringing hippocampal DNM1L, caspase 3, and synaptophysin…
Author: WebTeam
A new study published in the journal Environmental Toxicology and Pharmacology has found that cannabidiol – a compound of cannabis – may protect the heart from the dangerous side effects associated with the popular cancer drug doxorubicin. For the study, the “potential protective effect of cannabidiol, the major non-psychotropic Cannabis constituent, was investigated against doxorubicin cardiotoxicity in rats.” Researchers found that when rats were given doses of cannabidiol along with doses of doxorubicin, they showed no noticeable heart problems associated with the doxorubicin. However, rats which were exposed to doxorubicin, but not cannabidiol, displayed significant damage done by the drug.…
A new study published by the journal Neuropharmacology has found that cannabinoids may reduce aggression, and improve social interactions. For the study, researchers “examined the role of cannabinoid CB1 receptors (CB1r) in aggressive behavior”, and found that a compound meant to mimic THC (a prime compound of cannabis) “significantly decreased the aggression levels” of the mice that it was administered to. The researchers also examined mice which were bred without CB1 receptors, and found them to be more inherently aggressive than normal mice. Researchers conclude; “These results suggest that CB1r plays an important role in social interaction and aggressive behavior.”…
Contrary to prohibitionist propaganda, a new government-funded study published in the journal Neuropsychopharmacology has found that cannabis may combat the symptoms of schizophrenia by stimulating the body’s cannabinoid receptors. Researchers for the study examined rats with schizophrenia which were dosed with a chemical substance meant to mimic cannabinoids – compounds found in cannabis, as well as naturally produced in our body. Researchers found that the cannabinoids “reversed social withdrawal in PCP-treated rats via stimulation of CB1 receptors”; social withdrawal is one of the primary symptoms of schizophrenia. The study – which was funded by the Brain & Behavior Research Foundation…
London, UK, 5 August 2013: GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces top-line results from a 12 month placebo-controlled study of Sativex in patients with spasticity due to Multiple Sclerosis (MS). The study results confirm the reassuring safety profile of Sativex and provide further evidence of long-term efficacy. The study was a 12 month multicentre, double-blind, randomised parallel group, placebo-controlled study in 121 patients with MS spasticity. The study was required as a post-approval commitment by…
A new study published in this month’s issue of the journal Neuropsychopharmacology has found that compounds in cannabis may offer protection against chronic stress, including the memory and learning impairment that can come as a result. “Our findings suggest that cannabinoid receptor activation could represent a novel approach to the treatment of cognitive deficits that accompany a variety of stress-related neuropsychiatric disorders”, concludes the study. This is particularly important according to researchers, considering that repeated stress “is one of the environmental factors that precipitates and exacerbates mental illnesses like depression and anxiety as well as cognitive impairments”. During the study,…
A study released in last month’s issue of the journal Biochemical Pharmacology has found that even minuscule amounts of THC can provide protection from heart attacks, as well as reduce the potential cardiovascular damage associated with suffering one. For the study – which is titled An ultra-low dose of tetrahydrocannabinol provides cardioprotection – researchers administered extremely small amounts of THC; 0.002 mg/kg, which is up to 10,000 times less potent than the average joint. Despite how small the dose was, researchers found it to be effective at protecting against heart attacks when administered 2 to 48 hours before an attack,…
A new study conducted by the Department of Diagnostic and Biological Sciences at the University of Minnesota, and published in the most recent issue of the journal Neuroscience, has found that cannabinoids – compounds found in cannabis such as THC – can stop the pain associated with bone cancer by activating an individual’s cannabinoid receptors. “These results indicate that activation of either CB1 or CB2 receptors reduced the spontaneous activity of C-fiber nociceptors associated with tumor growth as well as their evoked responses”, states the study’s abstract, “Our results provide further evidence that activation of peripheral cannabinoid receptors may be…
Concord, NH: Governor Maggie Hassan has signed legislation, House Bill 573, into law making New Hampshire the 19th state to authorize the physician-recommended use of cannabis for qualified patients. Stated Hassan: “HB 573 legalizes the use of medical marijuana in a way that makes sense for the State of New Hampshire and gives health providers another option to help New Hampshire’s seriously ill patients. … By providing strong regulatory oversight and clear dispensing guidelines, this bill addresses many of the concerns that were expressed throughout the legislative process. The new law creates four state-sanctioned dispensing facilities to produce and distribute…
Marijuana smoking is not associated with the promotion of liver disease in subjects coinfected with both hepatitis C and the human immunodeficiency virus (HIV), according to data published online in the journal Clinical Infectious Diseases. Investigators at McGill University in Montreal and the University of Toronto assessed the impact of marijuana smoking on liver disease progression longitudinally in a cohort of nearly 700 subjects with HIV and the hepatitis C virus (HCV). Study participants at baseline reported having previously used cannabis, on average, some seven times per week, with 40 percent of subjects acknowledging having consumed cannabis daily. Participants were…
